Crimmins Gregory T, Herskovits Anat A, Rehder Kai, Sivick Kelsey E, Lauer Peter, Dubensky Thomas W, Portnoy Daniel A
Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA.
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10191-6. doi: 10.1073/pnas.0804170105. Epub 2008 Jul 16.
To gain insight into the interaction of intracellular pathogens with host innate immune pathways, we performed an unbiased genetic screen of Listeria monocytogenes mutants that induced an enhanced or diminished host innate immune response. Here, we show that the major facilitator superfamily of bacterial multidrug resistance transporters (MDRs) controlled the magnitude of a host cytosolic surveillance pathway, leading to the production of several cytokines, including type I IFN. Mutations mapping to repressors of MDRs resulted in ectopic expression of their cognate transporters, leading to host responses that were increased up to 20-fold over wild-type bacteria, and a 20-fold decrease in bacterial growth in vivo. Mutation of one of the MDRs, MdrM, led to a 3-fold reduction in the IFN-beta response to L. monocytogenes infection, indicating a pivotal role for MdrM in activation of the host cytosolic surveillance system. Bacterial MDRs had previously been associated with resistance to antibiotics and other toxic compounds. This report links bacterial MDRs and host immunity. Understanding the mechanisms through which live pathogens activate innate immune signaling pathways should lead to the discovery of adjuvants, vaccines, and perhaps new classes of therapeutics. Indeed, we show that the mutants identified in this screen induced vastly altered type I IFN response in vivo as well.
为深入了解细胞内病原体与宿主固有免疫途径的相互作用,我们对单核细胞增生李斯特菌突变体进行了无偏向性基因筛选,这些突变体可诱导宿主固有免疫反应增强或减弱。在此,我们表明细菌多药耐药转运蛋白(MDRs)的主要易化子超家族控制着宿主胞质监测途径的强度,从而导致包括I型干扰素在内的多种细胞因子的产生。定位到MDRs阻遏物的突变导致其同源转运蛋白的异位表达,从而使宿主反应比野生型细菌增加高达20倍,且体内细菌生长减少20倍。其中一种MDRs,即MdrM的突变导致对单核细胞增生李斯特菌感染的IFN-β反应降低3倍,表明MdrM在激活宿主胞质监测系统中起关键作用。细菌MDRs此前一直与对抗生素和其他有毒化合物的耐药性有关。本报告将细菌MDRs与宿主免疫联系起来。了解活病原体激活固有免疫信号通路的机制应能促成佐剂、疫苗以及可能新型治疗药物的发现。事实上,我们表明在此筛选中鉴定出的突变体在体内也诱导了I型干扰素反应的极大改变。